Occupier acquisitions increased 32% last year, a CBRE report found, and the trend contributed to industrial property values ...

Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call. An audio recording of the webcast will be available shortly after the call today on ...

Welcome to Plus Therapeutics' Fourth Quarter and Full Year ... the grant proceeds from a reward from the United States Department of Defense for $3 million in total to support the upcoming ReSPECT ...

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...

The HeartMate 3™ LVAD is the most advanced LVAD yet and the only one currently available in the United ... Cadrenal building build a pipeline of specialized cardiovascular therapeutics and ...

WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced ...

Augustine Therapeutics ... of companies, building market leaders in their respective therapeutic areas with accelerated patients' access globally, especially in Europe and the United States.

March 19, 2025 (GLOBE NEWSWIRE) -- Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond Therapeutics ... medicine to create more effective ...

SEOUL, South Korea--(BUSINESS WIRE)--Hudson Therapeutics, the U.S. subsidiary of Shaperon ... A kickoff meeting was recently held in March in the United States, marking a significant milestone in the ...

3 Reasons Investors Watch United Therapeutics (UTHR) Over the last six months, United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% ...

A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend ...